Bradley Foster & Sargent Inc. CT Grows Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Bradley Foster & Sargent Inc. CT increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,792 shares of the financial services provider’s stock after buying an additional 492 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in iShares Biotechnology ETF were worth $1,481,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in IBB. Kingsview Wealth Management LLC increased its holdings in iShares Biotechnology ETF by 7.6% in the 4th quarter. Kingsview Wealth Management LLC now owns 3,139 shares of the financial services provider’s stock valued at $426,000 after purchasing an additional 221 shares during the last quarter. Gladstone Institutional Advisory LLC increased its holdings in iShares Biotechnology ETF by 7.1% in the 4th quarter. Gladstone Institutional Advisory LLC now owns 6,316 shares of the financial services provider’s stock valued at $858,000 after purchasing an additional 420 shares during the last quarter. Corient Private Wealth LLC increased its holdings in iShares Biotechnology ETF by 1.0% in the 4th quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock valued at $11,778,000 after purchasing an additional 841 shares during the last quarter. Nemes Rush Group LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at approximately $322,000. Finally, Weil Company Inc. acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at approximately $310,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.2 %

iShares Biotechnology ETF stock opened at $147.52 on Thursday. The firm has a 50 day moving average price of $145.49 and a 200 day moving average price of $138.40. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.17.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.